Betamethasone Acetate, Florfenicol, Terbinafine Patent Expiration
About Veterinary Betamethasone Acetate, Florfenicol, Terbinafine
Betamethasone Acetate, Florfenicol, Terbinafine is used in a drug marketed by 1 company: Dechra Ltd.
Other drugs containing Betamethasone Acetate, Florfenicol, Terbinafine are: Osurnia .
Veterinary Betamethasone Acetate, Florfenicol, Terbinafine Patents
Given below is the list of patents protecting Betamethasone Acetate, Florfenicol, Terbinafine, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Osurnia | US7858115 | 23 Feb, 2027 | DECHRA, LTD. |
| Osurnia | US7846472 | 19 Nov, 2026 | DECHRA, LTD. |
| Osurnia | US7622138 | 21 Sep, 2026 | DECHRA, LTD. |
| Osurnia | US8361496 | 09 Jan, 2025 | DECHRA, LTD. |
| Osurnia | US6887487 | 31 Oct, 2022 | DECHRA, LTD. |
| Osurnia | US7404964 | 31 Oct, 2022 | DECHRA, LTD. |
Betamethasone Acetate, Florfenicol, Terbinafine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List